The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
3hon MSNOpinion
Contributor: Drug courts fail women, but there's a solution
These courts in L.A. and elsewhere operate on models built around male patterns of addiction and accountability. Hawaii tried ...
Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a clinical-stage biopharmaceutical company developing nature-derived psychedelic therapeutics, today announced that the first ...
Pivotal Phase 3 NOVA-2 trial in schizophrenia ongoing, topline data expected in 2H 2027LB-102 has potential to be the first benzamide approved ...
Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy, clinical trial design ...
We are building Definium to be a leader in psychiatry, focused on delivering a differentiated, scalable franchise for patients with depression, anxiety, and trauma, anchored by DT120 ODT, which we ...
A review of Erik Rempen's ShantyTown, a cozy city builder game.
Cartesian Therapeutics' lead asset, Descartes-08, demonstrated a 7.1-point MG-ADL reduction at 12 months in Phase 2b. Find ...
After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...
Investment of approx. JPY 700 million (USD 4.4 million 1) for preclinical development of an antimalarial drug Malaria is a serious infectious disease that affects more than 280 million people and ...
Lyell Immunopharma, Inc. (LYEL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 11:00 AM EDTCompany ParticipantsLynn Seely - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results